Man Group
TNXP icon

Man Group’s Tonix Pharmaceuticals TNXP Stock Holding History

Man Group’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
+18,669
New +$241K ﹤0.01% 2237
2026
Q1 		– Sell
-18,442
Closed -$288K – 2581
2025
Q4 		$288K Buy
+18,442
New +$340K ﹤0.01% 2030
2022
Q4 		– Sell
-1
Closed -$14K – 2223
2022
Q3 		$14K Buy
+1
New +$24.5K ﹤0.01% 1954
2022
Q2 		– Hold
0
– – – 1988

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Man Group's TNXP Position: Q2 2026 in Review

Man Group opened a new position in Tonix Pharmaceuticals (TNXP) in Q2 2026: 18,669 shares worth $238K. The stake represents ﹤0.01% of the portfolio and ranks #2237 among its holdings. This is a return to the name: Man Group previously reported a position in TNXP as recently as Q4 2025.

Man Group first reported a position in TNXP in Q3 2022 and has held it in 3 quarters since. The position peaked at $288K in Q4 2025. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Man Group held 18,669 shares of Tonix Pharmaceuticals worth $238K as of Q2 2026.
  • Tonix Pharmaceuticals was a new Man Group position in Q2 2026.
  • Tonix Pharmaceuticals made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2237 holding.
  • Man Group first reported a position in Tonix Pharmaceuticals in Q3 2022 and has held it in 3 quarters since.
  • Man Group's Tonix Pharmaceuticals position peaked at $288K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.